Atorvastatin Calcium
Product Images NDC 70934-615

5 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 615 30 Master Bottle Label Approval Rev A 04 20)

Label (70934 615 30 Master Bottle Label Approval Rev A 04 20)
Atorvastatin Calcium Tablets, USP 40 mg tablet label from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label indicates 30 tablets per bottle, Rx only, with storage instructions to keep the product at 20°-25°C (68°-77°F). It includes dosage directions referencing the package insert and cautions to keep out of reach of children. Several NDC entries and manufacturing details appear on the right side of the label.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph showing cumulative incidence percentage over 3.5 years for Atorvastatin versus placebo. The solid line represents Atorvastatin with lower cumulative incidence than the dashed line representing placebo, indicating comparative incidence rates over time. The graph includes a hazard ratio (HR) of 0.64 with confidence interval (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A cumulative hazard plot comparing Atorvastatin to placebo over a four-year follow-up period. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR 0.63) with confidence interval (0.48-0.83) and p-value (0.001), illustrating lower hazard in the Atorvastatin group.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph depicting the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2%). The graph includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium dihydrate, showing the molecular arrangement including aromatic rings, hydroxyl groups, fluorine substitution, and calcium ion complexation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.